PHASE II TRIAL OF LOW-DOSE METRONOMIC ORAL VINORELBINE COMBINED WITH BEVACIZUMAB IN PATIENTS WITH PRETREATED, ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC). PRELIMINARY RESULTS
JOURNAL OF THORACIC ONCOLOGY（2011）
关键词
metronomic vinorelbine,bevacizumab,NSCLC,phase II trial
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要